Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Achaogen Inc (AKAO)

Achaogen Inc (AKAO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Achaogen Inc 1 TOWER PLACE SUITE 300 SOUTH SAN FRANCISCO CA 94080 USA

www.achaogen.com P: 650-800-3636

Description:

Achaogen, Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of novel antibacterials to treat multi-drug resistant, or MDR, gram-negative infections. The Company is developing plazomicin, its lead product candidate, for the treatment of serious bacterial infections due to MDR enterobacteriaceae, including carbapenem-resistant enterobacteriaceae. Achaogen, Inc. is headquartered in South San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 7,027
Shares Outstanding, K 63,880
Annual Sales, $ 8,730 K
Annual Net Income, $ -186,510 K
Last Quarter Sales, $ 2,020 K
Last Quarter Net Income, $ -47,520 K
60-Month Beta 0.78
% of Insider Shareholders 7.80%
% of Institutional Shareholders 31.85%
Float, K 58,897
% Float 92.20%

Growth:

1-Year Return -99.16%
3-Year Return -96.76%
5-Year Return -99.20%
5-Year Revenue Growth -52.84%
5-Year Earnings Growth -172.06%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/03/19
Earnings Per Share ttm -3.74
EPS Growth vs. Prev Qtr 22.73%
EPS Growth vs. Prev Year 30.61%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AKAO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -357.49%
Return-on-Assets % -127.68%
Profit Margin % -2,136.43%
Debt/Equity 0.00
Price/Sales 0.79
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.13
Interest Coverage -87.39
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar